Top

Studies

Study type

Area

Group

Type of transplant

Text

Outcome after allogeneic SCT for MLL-PTD AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of transplant

Principal investigator

Marta Pratcorona

Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Lymphatic Leukaemia (ALL)

Acute Leukemia Working Party (ALWP)

Type of transplant

Principal investigator

Sabine BLUM , Yves Chalandon

Efficacy and Toxicity of ponatinib and 2nd generation TKI given after allogeneic SCT in Ph+ adult ALL.

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Leukemia Working Party (ALWP)

Type of transplant

Principal investigator

Klaus HIRSCHBUEHL

A multi-centre, multinational, prospective observational registry to collect safety and outcome data in patients diagnosed with severe hepatic VOD following hematopoietic stem cell transplantation (HSCT) and treated with Defitelio® or supportive care (control group)

Non-interventional Prospective Studies

Complications: non-infectious

Transplant Complications Working Party (TCWP)

Type of transplant

Principal investigator

Pr Mohamad Mohty

Allogeneic haematopoietic stem cell transplantation for chronic granulomatous disease (CGD)

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of transplant

Principal investigator

Outcome after busulfan or treosulfan conditioning for Wiskott-Aldrich syndrome (WAS) - a joint EBMT IEWP & SCETIDE study

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of transplant

Principal investigator

HSCT experience in patients with Interferon gamma receptor deficiencies

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of transplant

Principal investigator

Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of transplant

Principal investigator

Steve Robinson / Claire Burney

Incidence and prevalence of therapy-related Myeloid Neoplasms and myelodysplatci/myeloproliferative diseases (t-MN) in Germ Cell Tumors (GCT) patients

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of transplant

Principal investigator

Paolo Pedrazzoli

Incidence and prevalence of therapy-related Myeloid Neoplasms and myelodysplatci/myeloproliferative diseases (t-MN) in Breast Carcinoma

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of transplant

Principal investigator

Daniele Generali

Survival and late effects after hematopoietic stem cell transplantation in patients with HLH

Non-interventional Prospective Studies

Other non-malignant disorders

Paediatric Diseases Working Party (PDWP)

Type of transplant

Principal investigator

AnnaCarin Horne

Incidence of donor immune mediated hepatitis following HSCT in children. A Survey on behalf of the PDWP of the EBMT

Retrospective Studies

Complications: infectious

Paediatric Diseases Working Party (PDWP)

Type of transplant

Principal investigator

Need help?

First Name

Last Name

Email address

CIC number

Area of interest

Message box

I understand and accept that my personal data will be used for communication concerning the submitted query or request.

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to data.protection@ebmt.org